Human Recombinant IGF-BP6 (from (BTI-Tn-5B1-4) Hi-5 Insect cells)Supplier: PeproTech
350-07B-5UG 350-07B-1MG 350-07B-100UG 350-07B-250UG 350-07B-500UG 350-07B-20UG
10774-452EA 150.18 CAD10774-452 10774-462 10774-456 10774-458 10774-460 10774-454
Human Recombinant IGF-BP6 (from (BTI-Tn-5B1-4) Hi-5 Insect cells)
Proteins and Peptides
IGF-BPs control the distribution, function and activity of IGFs in various cell tissues and body fluids. IGF-BP6, which specifically inhibits IGF-II actions, is produced by bone cells and is the major IGF-BP present in cerebrospinal fluid. IGF-BP6 has been shown to inhibit IGF-II-dependent cancers such as neuroblastoma, colon cancer and rhabdomyosarcoma. Recombinant Human IGF-BP6 has a calculated mass of 22.3 kDa and consists of 213 amino acid residues, including the IGF-BP domain and thyroglobulin type-I domain. Recombinant Human IGF-BP6 migrates at an apparent molecular weight of approximately 23.0-30.0 kDa by SDS-PAGE analysis under non-reducing conditions.
Ordering information: For research use only. Not for use in diagnostic or therapeutic procedures.